Vaxart, Inc. (VXRT)
0.5005
-0.01
(-2.82%)
USD |
OTCM |
Aug 24, 16:00
Vaxart Market Cap : 121.54M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 121.54M |
| August 21, 2026 | 125.06M |
| August 20, 2026 | 126.20M |
| August 19, 2026 | 120.88M |
| August 18, 2026 | 120.22M |
| August 17, 2026 | 119.96M |
| August 14, 2026 | 131.98M |
| August 13, 2026 | 135.99M |
| August 12, 2026 | 135.94M |
| August 11, 2026 | 135.32M |
| August 10, 2026 | 139.63M |
| August 07, 2026 | 133.68M |
| August 06, 2026 | 138.42M |
| August 05, 2026 | 143.15M |
| August 04, 2026 | 145.70M |
| August 03, 2026 | 142.44M |
| July 31, 2026 | 130.36M |
| July 30, 2026 | 127.23M |
| July 29, 2026 | 116.53M |
| July 28, 2026 | 116.36M |
| July 27, 2026 | 108.66M |
| July 24, 2026 | 119.50M |
| July 23, 2026 | 120.59M |
| July 22, 2026 | 115.40M |
| July 21, 2026 | 121.49M |
| Date | Value |
|---|---|
| July 20, 2026 | 120.71M |
| July 17, 2026 | 124.33M |
| July 16, 2026 | 124.29M |
| July 15, 2026 | 127.95M |
| July 14, 2026 | 132.78M |
| July 13, 2026 | 130.86M |
| July 10, 2026 | 131.81M |
| July 09, 2026 | 132.13M |
| July 08, 2026 | 132.85M |
| July 07, 2026 | 132.85M |
| July 06, 2026 | 148.95M |
| July 02, 2026 | 154.50M |
| July 01, 2026 | 146.78M |
| June 30, 2026 | 146.06M |
| June 29, 2026 | 138.09M |
| June 26, 2026 | 130.24M |
| June 25, 2026 | 122.40M |
| June 24, 2026 | 125.54M |
| June 23, 2026 | 125.27M |
| June 22, 2026 | 129.16M |
| June 18, 2026 | 133.02M |
| June 17, 2026 | 137.28M |
| June 16, 2026 | 135.80M |
| June 15, 2026 | 138.81M |
| June 12, 2026 | 135.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 358.18M |
| Amgen, Inc. | 240.95B |
| Anika Therapeutics, Inc. | 290.28M |
| BioCryst Pharmaceuticals, Inc. | 2.500B |
| Imunon, Inc. | 7.792M |
Market Cap Related Metrics
| PE Ratio | 3.148 |
| PS Ratio | 0.491 |
| Price to Book Value | 1.476 |
| Price to Free Cash Flow | 3.575 |
| Price | 0.5005 |
| Earnings Yield | 31.77% |
| Operating PE Ratio | 3.013 |
| Normalized PE Ratio | 3.148 |